General Information
Revision date
2015-06-16
Product name
Arestin (minocycline hydrochloride powder)
1.2.1 Relevant identified uses
l Oral care. ARESTIN® may be used as part of a periodontal maintenance program which includes good oral hygiene, and scaling and root planing
1.2.2. Uses advised against
l Refer to the product insert and/or prescribing information for restrictions on use and contraindications
Manufacturer Name
l Valeant Pharmaceuticals North America, LLC
Icons in SDS
Company Information
company name
l Valeant Pharmaceuticals North America, LLC
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H351, H360
Hazard statements
Code
Statements
H351
Suspected of causing cancer
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Classification of the substance or mixture UN GHS l Acute Toxicity Oral 5 Reproductive Toxicity 1 Carcinogenicity 2
2.2 Label elements
UN GHS DANGER
Hazard statements
May be harmful if swallowed May damage fertility or the unborn child. Suspected of causing cancer.
Precautionary statements
Prevention l Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Wash thoroughly after handling. Response l IF exposed or concerned: Get medical advice/attention. Storage/Disposal l Keep tightly closed. Store at controlled room temperature 2025ºC/6877ºF (excursions permitted to 1530ºC/5986ºF), to maintain product integrity. Use before date marked on carton and/or container. Dispose of content and/or container in accordance with local, regional, national, and/or international regulations.
2.3 Other hazards
UN GHS l No data available
2.1 Classification of the substance or mixture
UN GHS l Acute Toxicity Oral 5 Reproductive Toxicity 1 Carcinogenicity 2